Methyllucidone is a STAT3 inhibitor. It acts by regulating the expression of the protein tyrosine phosphatase MEG2. References: Jin Y, Kim YH, Park JY, Lee YJ, Oh HM, Choi SK, Han DC, Kwon BM. Methyllucidone inhibits STAT3 activity by regulating the expression of the protein tyrosine phosphatase MEG2 in DU145 prostate carcinoma cells. Bioorg Med Chem Lett. 2018 Mar 1;28(5):853-857. doi: 10.1016/j.bmcl.2018.02.012. Epub 2018 Feb 8. PubMed PMID: 29456111.

纯度：≥98%

CAS：19956-54-8